Aurinia Pharmaceuticals Inc (AUPH) receives a Buy rating from Jefferies

Roman Campbell

Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug 01 ’25. In the deal valued at $10.12 per share,1,000,000 shares were bought. As a result of this transaction, TANG KEVIN now holds 11,029,500 shares worth roughly $161.14 million.

Then, TANG KEVIN bought 200,000 shares, generating $2,336,000 in total proceeds. Upon buying the shares at $11.68, the Director now owns 11,329,500 shares.

Before that, TANG KEVIN bought 100,000 shares. Aurinia Pharmaceuticals Inc shares valued at $1,134,000 were divested by the Director at a price of $11.34 per share. As a result of the transaction, TANG KEVIN now holds 11,129,500 shares, worth roughly $162.6 million.

Jefferies upgraded its Aurinia Pharmaceuticals Inc [AUPH] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who decreased its forecast for the stock in early November from “an Outperform” to “a Sector perform”. Oppenheimer revised its rating on November 04, 2022. It rated AUPH as “a Perform” which previously was an “an Outperform”.

Price Performance Review of AUPH

On Friday, Aurinia Pharmaceuticals Inc [NASDAQ:AUPH] saw its stock jump 4.73% to $14.61. Over the last five days, the stock has gained 10.93%. Aurinia Pharmaceuticals Inc shares have risen nearly 99.59% since the year began. Nevertheless, the stocks have risen 62.69% over the past one year. While a 52-week high of $16.20 was reached on 11/04/25, a 52-week low of $6.55 was recorded on 02/27/25.

Levels Of Support And Resistance For AUPH Stock

The 24-hour chart illustrates a support level at 14.32, which if violated will result in even more drops to 14.04. On the upside, there is a resistance level at 15.08. A further resistance level may holdings at 15.56.

How much short interest is there in Aurinia Pharmaceuticals Inc?

A steep rise in short interest was recorded in Aurinia Pharmaceuticals Inc stocks on 2025-10-15, dropping by -0.59 million shares to a total of 8.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-15 was 8.98 million shares. There was a decline of -7.01%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.